Safety and Efficacy of Exemestane Plus Dasatinib Versus Placebo for Advanced ER+ Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography
- Status
- COMPLETED
- Phase
- PHASE3
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Abatacept to Treat Refractory Sarcoidosis
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma
- Status
- WITHDRAWN
- Phase
- PHASE1
Compression Device Safety Study
- Status
- COMPLETED
- Phase
- PHASE2
Compression Device Safety Study on Edema
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites
- Status
- COMPLETED
- Phase
- PHASE3
Study of MDX-1411 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Multiple Ascending Dose (MDX1105-01)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2, Multi-center, Open-label, Dose-escalation Study of Elotuzumab(Humanized Anti-CS1 Monoclonal IgG1 Antibody) and Bortezomib in Subjects With Multiple Myeloma Following One to Three Prior Therapies.
- Status
- TERMINATED
- Phase
- PHASE1